News | October 05, 2012

Advocate Health Care and GE Healthcare Join to Further Reduce Patient CT Radiation Dose

GE Blueprint Advocate Healthcare Radiation Dose Management

October 5, 2012 — Advocate Health Care, one of the nation's top health systems and the largest integrated health care system in the state of Illinois, and GE Healthcare, a national leader in low dose, high performance imaging, announced a joint effort to help further reduce radiation dose in computed tomography (CT). The goal is to optimize care for patients needing imaging procedures and reduce radiation where possible without adversely impacting image quality. It’s one of the first announcements of the GE Blueprint for low dose, a comprehensive campaign in which GE Healthcare is working alongside leading U.S. health systems to further reduce radiation dose in CT imaging. Leaders from Advocate and GE Healthcare unveiled the Advocate-based GE Blueprint for low dose today during an event at Advocate Lutheran General Hospital.

“Advocate Health Care is committed to delivering the best health outcomes for our patients,” said John Anastos, D.O., chairman of radiology at Advocate Lutheran General Hospital. “By providing the best-in-class diagnostic capabilities, and leveraging advanced technologies to capture the highest-quality CT images, we ensure all of our patients receive the lowest possible radiation dose in each and every procedure.”

Advocate’s radiation dose reduction program includes a plan to install the GE DoseWatch software on all of its diagnostic and radiation therapy CT scanners. The technology allows for precise management of dose data. Advocate will also participate in the American College of Radiology (ACR) Dose Index Registry (DIR). The national database allows CT facilities to compare their dose levels to other CT facilities across the country.

Additionally, Advocate will hold an annual radiation dose symposium designed to educate associates on the latest in CT technology, clinical protocols and best practices for radiation dose reduction. A CT steering committee will oversee and monitor the program’s effectiveness.

CT imaging is a critical tool in helping physicians diagnose disease and has positively impacted millions of lives. Historically, physicians have had to balance the desires for high image quality and low radiation dose levels in CT. Through ongoing collaboration with healthcare leaders including Advocate, GE is changing the equation in diagnostic imaging. Launched in June 2012, GE Blueprint offers a comprehensive approach based on an assessment of a health care provider’s technology, people and processes and helps identify breakthrough imaging technologies, system-specific solutions and processes, and comprehensive imaging “blueprints” to help providers achieve low-dose, high-definition diagnostic capabilities. Additionally, solutions such as DoseWatch, a first-of-its-kind management tool, will further enable Advocate Health Care and other providers to measure, track and optimize patient radiation dose over time.

“GE Healthcare has long collaborated with healthcare providers as they work to continuously reduce radiation dose in CT imaging,” said Steve Gray, vice president and general manager for computed tomography at GE Healthcare. “Building upon our announcement last November to invest more than $800 million in the development of low-dose technologies over 15 years, GE Blueprint will help hospitals optimize imaging departments systemically and significantly.”

Leveraging a team of “Low Dose Architects,” GE Blueprint helps Advocate and other hospital systems assess their dose management programs, and collaborates on recommendations for end-to-end dose management, including staff education, process improvements, equipment assessments and CT technologies that can enable low-dose, high-definition imaging.

For more information: www.gehealthcare.com/GEBlueprint


Related Content

News | Computed Tomography (CT)

July 16, 2024 — Arineta, a leader in advancing cardiovascular imaging solutions through cutting-edge technology, proudly ...

Home July 16, 2024
Home
News | Computed Tomography (CT)

May 1, 2024 —In this 3-stage study, 3 cohorts were used for diagnostic performance, and prognostic performance ...

Home May 01, 2024
Home
News | Computed Tomography (CT)

April 22, 2024 — A new study showed that a non-invasive imaging test can help identify patients with coronary artery ...

Home April 22, 2024
Home
Feature | Computed Tomography (CT) | By Alberto Morales, MD

Cardiac CT scans, recommended by the American College of Cardiology (ACC) and the American Heart Association (AHA) as ...

Home March 20, 2024
Home
News | Computed Tomography (CT)

February 20, 2024 — Ultrahigh-spatial-resolution photon-counting detector CT improved assessment of coronary artery ...

Home February 20, 2024
Home
News | Computed Tomography (CT)

HeartFlow is offering a free webinar based on a recent study that measured the ability of the of its roadmap analysis to ...

Home January 15, 2024
Home
News | Computed Tomography (CT)

December 19, 2023 — Siemens Healthineers announced the Food and Drug Administration (FDA) clearance of the Somatom Pro ...

Home December 19, 2023
Home
Feature | Computed Tomography (CT) | By Andrew Michalski, PhD and Rohit Sood MD, PhD

Coronary artery disease (CAD), also known as ischemic heart disease, is the most common heart disease with a prevalence ...

Home December 05, 2023
Home
News | Computed Tomography (CT)

October 26, 2023 — HeartFlow, Inc., a leader in non-invasive integrated artificial intelligence (AI) heart care ...

Home October 26, 2023
Home
News | Computed Tomography (CT)

October 13, 2023 — Arineta Cardiac Imaging is excited to announce the FDA 510(k) clearance of the SpotLight and ...

Home October 13, 2023
Home
Subscribe Now